Refinement and Testing of Interventions to Sustain ADHD Treatment Effects Across Settings and Developmental Transitions (R34 Clinical Trial Required)
Funding Opportunity RFA-MH-20-100 from the NIH Guide for Grants and Contracts. NIMH seeks applications for pilot projects to evaluate the preliminary effectiveness of augmented or modified interventions designed to promote sustained improvement in attention-deficit/hyperactivity disorder (ADHD) symptoms and functional impairments across settings and transitions in children, adolescents, and young adults. An emphasis is placed on trials that go beyond seeking incremental gains in intervention effects, and instead take a theory-driven, empirical approach to applying modifications that will have a significant and enduring im...
Source: NIH Funding Opportunities (Notices, PA, RFA) - February 4, 2019 Category: Research Source Type: funding

National Public Health Practice and Resource Centers for Children with Attention Deficit/Hyperactivity Disorder or Tourette Syndrome
Funding Opportunity Number: CDC-RFA-DD15-150502CONT16 Opportunity Category: ContinuationFunding Instrument Type: Cooperative AgreementCategory of Funding Activity: HealthCFDA Number: 93.312Eligible Applicants Others (see text field entitled "Additional Information on Eligibility" for clarification)Agency Name: HHS-CDCClosing Date: May 02, 2016Award Ceiling: $0Expected Number of Awards: Creation Date: Feb 26, 2016Funding Opportunity Description: National Public Health Practice and Resource Centers for Children with Attention Deficit/Hyperactivity Disorder or Tourette Syndrome (Source: Grants.gov)
Source: Grants.gov - February 27, 2016 Category: Research Tags: Health Source Type: funding

National Public Health Practice and Resource Centers for Children with Attention Deficit/Hyperactivity Disorder or Tourette Syndrome
Funding Opportunity Number: CDC-RFA-DD15-1505 Opportunity Category: DiscretionaryFunding Instrument Type: Cooperative AgreementCategory of Funding Activity: HealthCFDA Number: 93.312Eligible Applicants Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"Agency Name: HHS-CDCClosing Date: May 11, 2015Award Ceiling: $900,000Expected Number of Awards: 2Creation Date: Mar 08, 2015Funding Opportunity Description: The purpose of the National Public Health Practice and Resource Centers (NPHPRC) on Health for Chi...
Source: Grants.gov - March 9, 2015 Category: Research Tags: Health Source Type: funding

Validation of Pediatric Patient Reported Outcomes in Chronic Diseases (PEPR) Consortium (U19)
Funding Opportunity Number: RFA-AR-15-014 Opportunity Category: DiscretionaryFunding Instrument Type: Cooperative AgreementCategory of Funding Activity: HealthCFDA Number: 93.846Eligible Applicants State governmentsCounty governmentsCity or township governmentsSpecial district governmentsIndependent school districtsPublic and State controlled institutions of higher educationNative American tribal governments (Federally recognized)Public housing authorities/Indian housing authoritiesNative American tribal organizations (other than Federally recognized tribal governments)Nonprofits having a 501(c)(3) status with th...
Source: Grants.gov - March 6, 2015 Category: Research Tags: Health Source Type: funding

Validation of Pediatric Patient Reported Outcomes in Chronic Diseases (PEPR) Consortium (U19)
Funding Opportunity RFA-AR-15-014 from the NIH Guide for Grants and Contracts. The purpose of this FOA is to solicit applications for the Validation of Pediatric Patient Reported Outcomes in Chronic Diseases (PEPR) Consortium. The NIAMS, on behalf of the National Institutes of Health, intends to capitalize on recent advances in the science of Patient Reported Outcomes (PROs) to measure the patient experience in clinical care and research in children with a variety of chronic diseases and conditions (e.g., asthma, juvenile arthritis, cystic fibrosis, diabetes, obesity and overweight, chronic kidney disease, inflammatory ...
Source: NIH Funding Opportunities (Notices, PA, RFA) - March 6, 2015 Category: Research Source Type: funding

Pharmacokinetic/Pharmacodynamic (PK/PD) Studies of Methylphenidate Extended Release Products in Attention Deficit Hyperactivity Disorder (ADHD) Patients (U01)
Funding Opportunity Number: RFA-FD-14-015 Opportunity Category: DiscretionaryFunding Instrument Type: Cooperative AgreementCategory of Funding Activity: HealthScience and Technology and other Research and DevelopmentCFDA Number: 93.103Eligible Applicants State governmentsCounty governmentsCity or township governmentsSpecial district governmentsIndependent school districtsPublic and State controlled institutions of higher educationNative American tribal governments (Federally recognized)Public housing authorities/Indian housing authoritiesNative American tribal organizations (other than Federally recognized tribal...
Source: Grants.gov - April 29, 2014 Category: Research Tags: Health Science and Technology and other Research and Development Source Type: funding

Pharmacokinetic/Pharmacodynamic (PK/PD) Studies of Methylphenidate Extended Release Products in Attention Deficit Hyperactivity Disorder (ADHD) Patients (U01)
Funding Opportunity RFA-FD-14-015 from the NIH Guide for Grants and Contracts. The purpose of this project is to conduct a prospective PK/PD study in attention deficit hyperactivity disorder (ADHD) patients to link the PK profiles to the time-course of PD activity of methylphenidate extended release products in order to identify additional PK metrics (if any) that may impact the therapeutic equivalence of methylphenidate extended release products. The findings from the PK/PD study will help establish scientific and regulatory standards for assuring therapeutic equivalence of generic methylphenidate extended release prod...
Source: NIH Funding Opportunities (Notices, PA, RFA) - April 25, 2014 Category: Research Source Type: funding

Pharmacometric Modeling and Simulation for Generic Drugs Evaluation
The objectives of this project are to develop quantitative models for generic drugs evaluation in the following areas: 1. Population pharmacokinetic and pharmacodynamic, dose-efficacy, and dose-toxicity modeling and simulation for narrow therapeutic index (NTI) drugs. The goal is to develop models and modeling approaches that will help FDA classify drugs as having a narrow therapeutic index and identify those products that have a clinical use profile that requires tighter control of product quality and equivalence attributes. 2. Pharmacometric modeling and simulation for generic drug substitutability evaluation and post ...
Source: Grants.gov - March 28, 2014 Category: Research Tags: Health Science and Technology and other Research and Development Source Type: funding

National Public Health Practice and Resource Centers for Children with Attention-Deficit/Hyperactivity Disorder or Tourette Syndrome
Funding Opportunity Number: CDC-RFA-DD13-1302 Opportunity Category: DiscretionaryFunding Instrument Type: Cooperative AgreementCategory of Funding Activity: HealthCFDA Number: 93.184Eligible Applicants Others (see text field entitled "Additional Information on Eligibility" for clarification)Agency Name: HHS-CDCClosing Date: Jul 09, 2013Award Ceiling: $800,000Expected Number of Awards: 2Creation Date: May 17, 2013Funding Opportunity Description: The purpose of the National Public Health Practice and Resource Centers (NPHPRC) on Health for Children with Attention-Deficit/Hyperactivity Disorder (ADH...
Source: Grants.gov - May 20, 2013 Category: Research Tags: Health Source Type: funding